BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 25860543)

  • 1. Evidence for bactericidal activities of lipidic nanoemulsions against Pseudomonas aeruginosa.
    Singh N; Verma SM; Singh SK; Verma PR
    Antonie Van Leeuwenhoek; 2015 Jun; 107(6):1555-68. PubMed ID: 25860543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphological transitions of Bacillus subtilis in the presence of food-grade lipidic nanoemulsions.
    Singh N; Hussain A; Kumar Singh S
    J Food Sci; 2020 Apr; 85(4):1223-1230. PubMed ID: 32147836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of manuka honey on the structure of Pseudomonas aeruginosa.
    Henriques AF; Jenkins RE; Burton NF; Cooper RA
    Eur J Clin Microbiol Infect Dis; 2011 Feb; 30(2):167-71. PubMed ID: 20936493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Manuka honey is bactericidal against Pseudomonas aeruginosa and results in differential expression of oprF and algD.
    Roberts AEL; Maddocks SE; Cooper RA
    Microbiology (Reading); 2012 Dec; 158(Pt 12):3005-3013. PubMed ID: 23082035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibacterial activity and morphological changes of Pseudomonas aeruginosa cells after exposure to Vernonia cinerea extract.
    Latha LY; Darah I; Kassim MJ; Sasidharan S
    Ultrastruct Pathol; 2010 Aug; 34(4):219-25. PubMed ID: 20594042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azithromycin and ciprofloxacin: a possible synergistic combination against Pseudomonas aeruginosa biofilm-associated urinary tract infections.
    Saini H; Chhibber S; Harjai K
    Int J Antimicrob Agents; 2015 Apr; 45(4):359-67. PubMed ID: 25604277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of ciprofloxacin in its synergistic effect with fosfomycin on drug-resistant strains of Pseudomonas aeruginosa.
    Yamada S; Hyo Y; Ohmori S; Ohuchi M
    Chemotherapy; 2007; 53(3):202-9. PubMed ID: 17356268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pharmacokinetic/pharmacodynamic model developed for the effect of colistin on Pseudomonas aeruginosa in vitro with evaluation of population pharmacokinetic variability on simulated bacterial killing.
    Mohamed AF; Cars O; Friberg LE
    J Antimicrob Chemother; 2014 May; 69(5):1350-61. PubMed ID: 24474432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bactericidal effect of colistin on planktonic Pseudomonas aeruginosa is independent of hydroxyl radical formation.
    Brochmann RP; Toft A; Ciofu O; Briales A; Kolpen M; Hempel C; Bjarnsholt T; Høiby N; Jensen PØ
    Int J Antimicrob Agents; 2014 Feb; 43(2):140-7. PubMed ID: 24315789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidences for anti-mycobacterium activities of lipids and surfactants.
    Hussain A; Singh SK
    World J Microbiol Biotechnol; 2016 Jan; 32(1):7. PubMed ID: 26712622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-biofilm and resistance suppression activities of CXA-101 against chronic respiratory infection phenotypes of Pseudomonas aeruginosa strain PAO1.
    Riera E; Macià MD; Mena A; Mulet X; Pérez JL; Ge Y; Oliver A
    J Antimicrob Chemother; 2010 Jul; 65(7):1399-404. PubMed ID: 20435779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imipenem: morphological changes and lethal effects on Pseudomonas aeruginosa.
    Carlone NA; Ferrero M; Cuffini AM; Cavallo R
    Drugs Exp Clin Res; 1987; 13(10):623-9. PubMed ID: 3123190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between tobramycin and CSA-13 on clinical isolates of Pseudomonas aeruginosa in a model of young and mature biofilms.
    Nagant C; Tré-Hardy M; El-Ouaaliti M; Savage P; Devleeschouwer M; Dehaye JP
    Appl Microbiol Biotechnol; 2010 Sep; 88(1):251-63. PubMed ID: 20625718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activities of tachyplesin III against Pseudomonas aeruginosa.
    Cirioni O; Giacometti A; Kamysz W; Silvestri C; Riva A; Della Vittoria A; Abbruzzetti A; Lukasiak J; Scalise G
    Peptides; 2007 Apr; 28(4):747-51. PubMed ID: 17331619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro efficacy of various antibiotic combinations against Pseudomonas aeruginosa isolates.
    Nazli E; Zer Y; Eksi F
    J Int Med Res; 2015 Apr; 43(2):217-25. PubMed ID: 25547417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of colistin combined with doripenem at clinically relevant concentrations against multidrug-resistant Pseudomonas aeruginosa in an in vitro dynamic biofilm model.
    Lora-Tamayo J; Murillo O; Bergen PJ; Nation RL; Poudyal A; Luo X; Yu HY; Ariza J; Li J
    J Antimicrob Chemother; 2014 Sep; 69(9):2434-42. PubMed ID: 24833752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bactericidal effect of poly(acrylamide/itaconic acid)-silver nanoparticles synthesized by gamma irradiation against Pseudomonas aeruginosa.
    Eid M; Araby E
    Appl Biochem Biotechnol; 2013 Sep; 171(2):469-87. PubMed ID: 23857355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural alterations in Pseudomonas aeruginosa by zingerone contribute to enhanced susceptibility to antibiotics, serum and phagocytes.
    Kumar L; Chhibber S; Harjai K
    Life Sci; 2014 Nov; 117(1):24-32. PubMed ID: 25277943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of antibiotic combinations against Pseudomonas aeruginosa biofilm and planktonic cultures.
    Tré-Hardy M; Vanderbist F; Traore H; Devleeschouwer MJ
    Int J Antimicrob Agents; 2008 Apr; 31(4):329-36. PubMed ID: 18280117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of enhanced activity of liposome-entrapped aminoglycosides against resistant strains of Pseudomonas aeruginosa.
    Mugabe C; Halwani M; Azghani AO; Lafrenie RM; Omri A
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2016-22. PubMed ID: 16723560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.